Skip to main content
Caplight Logo









InStride Health

InStride Health

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://instride.health/

Last Round

Series C

Jun 15, 2026

Total Funding Raised

$86M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

InStride Health is a healthcare company that provides a virtual specialty outpatient care platform for children, teens, and young adults with anxiety, OCD, and related disorders.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

pediatric mental healthvirtual mental healthcaretelehealthanxiety treatmentOCD treatmentvalue-based carebehavioral healthdigital healthcaregiver supportclinical operationsB2B2C healthcareAI scribemental health techvirtual clinichealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InStride Health Comparables

Compare InStride Health with similar companies based on industry and business-model similarity.

InStride Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brightline
86%
Hazel Health
81%
Handspring Health
80%

InStride Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 15, 2026
Series BMar 27, 2024
Series AOct 3, 2022

Key People

Founding team and executive leadership

James McElhiney

Chief Technology Officer Co-founder

Founding Team

Kathryn Boger

Chief Clinical Officer And Co-Founder

Founding Team

Mona Potter

Chief Medical Officer and co-founder

Founding Team

John Voith

CEO and Co-Founder

Founding Team

InStride Health Investors

Notable investors and investment history

InStride Health investors
InvestorRounds
Mass General Brigham InnovationSeries C, Series A, Series B
FMZ VenturesSeries C
ValtruisSeries C, Series B, Series A
General CatalystSeries C, Series B
HopelabSeries B
406 VenturesSeries C, Series B, Series A
Echo Health VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 15, 2026

    $30M round led by Echo Health Ventures and FMZ Ventures.

  • May 31, 2026

    Added Aetna, Inc. as a customer in Health Insurance.

InStride Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

InStride Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InStride Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range317
Year Founded2021
Last FundingJun 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?